antibiotic dosing during renal failure
DESCRIPTION
Lecture to 3rd year pharmacy students in an ID electiveTRANSCRIPT
Antibiotic Dosing Antibiotic Dosing During Renal During Renal FailureFailureFebruary 1, 2010February 1, 2010Sarah Nelson, Pharm.D.Sarah Nelson, Pharm.D.
Critical Care Pharmacy ResidentCritical Care Pharmacy Resident
ObjectivesObjectives
Explain the necessity of dose Explain the necessity of dose adjustments during renal impairmentadjustments during renal impairment
Demonstrate how to calculate GFR using Demonstrate how to calculate GFR using various meansvarious means
Compare various types of dialysis and Compare various types of dialysis and their associated dosing adjustmentstheir associated dosing adjustments
Utilize standard practice references to Utilize standard practice references to identify dosage adjustment identify dosage adjustment recommendationsrecommendations
Kidney DiseaseKidney Disease
Over 19 million adults have chronic Over 19 million adults have chronic kidney diseasekidney disease ~80,000 new diagnoses/year~80,000 new diagnoses/year
Kidney disease is the 9Kidney disease is the 9thth leading cause leading cause of death of death
Wargo et al. Comparison of the Modification of Diet in Renal Disease and Cockroft-Gault Equations for Antimicrobial Dosage Adjustments. The Annals of Pharmacotherapy. 2006;40:1248-1253
Importance of Renal Importance of Renal FunctionFunction Kidney and liver are major routes of Kidney and liver are major routes of
elimination for antimicrobials & metaboliteselimination for antimicrobials & metabolites Most antimicrobials follow first order kineticsMost antimicrobials follow first order kinetics
Plasma levels for antimicrobials are a Plasma levels for antimicrobials are a function of:function of: dose, bioavailability, Vd, rate of metabolism, & dose, bioavailability, Vd, rate of metabolism, &
rate of excretionrate of excretion Decreased excretion=increased plasma levelsDecreased excretion=increased plasma levels
Livornese et al. Use of antibacterial agents in renal failure. Infect Dis Clin N Am. 2004;18:551-579
Importance of Renal Importance of Renal FunctionFunction
Consequences of increased plasma Consequences of increased plasma antimicrobial levels:antimicrobial levels: Neurotoxicity (ex. aminoglycosides)Neurotoxicity (ex. aminoglycosides) Nephrotoxicity (ex. vancomycin)Nephrotoxicity (ex. vancomycin) Thrombocytopenia (ex. TMX-SMP)Thrombocytopenia (ex. TMX-SMP)
Concentration of antimicrobials may not Concentration of antimicrobials may not attain adequate levelsattain adequate levels Urinary tract infectionsUrinary tract infections
NitrofurantionNitrofurantion
Renal ExcretionRenal Excretion
http://www.unckidneycenter.org/images/glomerulus.jpg
Risk Factors/Markers of Risk Factors/Markers of Renal ImpairmentRenal Impairment
Clinically observed:Clinically observed: AgeAge Urine outputUrine output
Laboratory parameters:Laboratory parameters: Serum creatinineSerum creatinine Urine creatinineUrine creatinine Urine proteinUrine protein Urine RBCsUrine RBCs
Calculating GFRCalculating GFR GFR: glomerular filtration rateGFR: glomerular filtration rate
Most accurate measure of kidney functionMost accurate measure of kidney function Can be directly measured but is costly and Can be directly measured but is costly and
often inaccurateoften inaccurate Estimate based on substances that are Estimate based on substances that are
filtered in the glomerulusfiltered in the glomerulus Must be freely filteredMust be freely filtered Must have minimal secretion/reabsorption in Must have minimal secretion/reabsorption in
renal tubulesrenal tubules i.e. creatininei.e. creatinine
Wargo et al. Comparison of the Modification of Diet in Renal Disease and Cockroft-Gault Equations for Antimicrobial Dosage Adjustments. The Annals of Pharmacotherapy. 2006;40:1248-1253
Calculating GFRCalculating GFR
2 current techniques used to estimate renal 2 current techniques used to estimate renal functionfunction Modification of Diet in Renal Disease (MDRD)Modification of Diet in Renal Disease (MDRD)
Estimates GFREstimates GFR
Cockroft-GaultCockroft-Gault Estimates creatinine clearance (CrCl)Estimates creatinine clearance (CrCl)
Moranville, M et al. Implications of using modification of diet in renal disease versus Cockroft-Gault equations for renal dosing adjustments. Am J Health-Syst Pharm. 2009;66:154-161
MDRDMDRD Developed as an alternate approach for Developed as an alternate approach for
staging renal diseasestaging renal disease Automatically calculated by most Automatically calculated by most
institutional laboratory softwareinstitutional laboratory software Supported by NKDEP to increase detection of Supported by NKDEP to increase detection of
renal impairmentrenal impairment Is not validated for use in medication Is not validated for use in medication
dosingdosing Manufacturer dosage adjustments based on Manufacturer dosage adjustments based on
creatinine clearance (Cockroft-Gault), not GFRcreatinine clearance (Cockroft-Gault), not GFR
Moranville, M et al. Implications of using modification of diet in renal disease versus Cockroft-Gault equations for renal dosing adjustments. Am J Health-Syst Pharm. 2009;66:154-161
MDRDMDRD 2 different equations exist2 different equations exist
6 variable: 6 variable: 170 x SCr170 x SCr–0.999–0.999 x age x age–0.176–0.176 x SUN x SUN–0.170 –0.170 x SAlbx SAlb+0.318+0.318 x 1.180 x 1.180
(African American) x 0.762 (female)(African American) x 0.762 (female) 4 variable: 4 variable:
186.3 x Scr186.3 x Scr--1.154--1.154 x age x age -0.203-0.203 x 1.210 (African American) x x 1.210 (African American) x 0.742 (female)0.742 (female)
Units: mL/min/1.73 mUnits: mL/min/1.73 m22
Pros of the MDRD More accurate during severe renal impairmentMore accurate during severe renal impairment Accounts for ethnicityAccounts for ethnicity
Cons of the MDRDCons of the MDRD Neither address weight, heightNeither address weight, height Cannot use for dose adjustmentsCannot use for dose adjustments
Golik et al. Comparison of Dosing Recommendations for Antimicrobial Drugs Based on Two Methods for Assessing Kidney Function: Cockroft-Gault and Modification of Diet in Renal Disease. Pharmacotherapy. 2008;28(9):1125-1132
Cockroft-GaultCockroft-Gault
ESTIMATES renal functionESTIMATES renal function Measures the rate of creatinine clearance Measures the rate of creatinine clearance
via the glomerulusvia the glomerulus Creatinine: breakdown product of muscleCreatinine: breakdown product of muscle
Freely filteredFreely filtered Fluctuates with diet, muscle mass, medicationsFluctuates with diet, muscle mass, medications
Used when studying pharmacokinetics of Used when studying pharmacokinetics of medications coming/on the marketmedications coming/on the market
Moranville, M et al. Implications of using modification of diet in renal disease versus Cockroft-Gault equations for renal dosing adjustments. Am J Health-Syst Pharm. 2009;66:154-161
Cockroft-GaultCockroft-Gault
(140 – age) x weight(140 – age) x weight x 0.85 (females) x 0.85 (females)
( 72 x SCr)( 72 x SCr)
Use actual body weight if patient is <IBWUse actual body weight if patient is <IBW Use IBW if the actual body weight is Use IBW if the actual body weight is
<25% above IBW<25% above IBW Use ABW (adjusted body weight) if the Use ABW (adjusted body weight) if the
actual body weight is >25% above IBWactual body weight is >25% above IBW
Golik et al. Comparison of Dosing Recommendations for Antimicrobial Drugs Based on Two Methods for Assessing Kidney Function: Cockroft-Gault and Modification of Diet in Renal Disease. Pharmacotherapy. 2008;28(9):1125-1132
Weight CalculationsWeight Calculations
IBWIBWfemales females (kg)= 45.5 + 2.3(height(kg)= 45.5 + 2.3(heightinches inches - 60)- 60)
IBWIBWmalesmales(kg)= 50 + 2.3(height(kg)= 50 + 2.3(heightinches inches - 60)- 60)
ABW= IBW + 0.4(actual weight – IBW)ABW= IBW + 0.4(actual weight – IBW)
Cockroft-GaultCockroft-Gault
Pros to Cockroft-GaultPros to Cockroft-Gault Easy to make dosage recommendationsEasy to make dosage recommendations Easy to calculateEasy to calculate
Cons to Cockroft-GaultCons to Cockroft-Gault Not a true marker of renal impairmentNot a true marker of renal impairment May OVERESTIMATE renal function in May OVERESTIMATE renal function in
elderly populationelderly population Some clinicians round SCr to 1.0mg/dLSome clinicians round SCr to 1.0mg/dL
TIME OUT!!TIME OUT!! Example #1: Example #1:
36 y/o Caucasian female with renal disease due to 36 y/o Caucasian female with renal disease due to IDDM. IDDM.
Current labs:Current labs:
GFR calculated with MDRD: 32 mL/min/1.73 mGFR calculated with MDRD: 32 mL/min/1.73 m22
CrCl calculated with Cockroft-Gault: 37 mL/min/1.73 mCrCl calculated with Cockroft-Gault: 37 mL/min/1.73 m22
SCr Weight Height
1.9 mg/dL 57 kg 5'3"
Pause for the Cause!Pause for the Cause! Example #2: 62 y/o AAM with renal disease secondary Example #2: 62 y/o AAM with renal disease secondary
to malignant hypertensionto malignant hypertension Current labs:Current labs:
Weight to use: 86 kgWeight to use: 86 kg
GFR calculated with GFR: 27 mL/min/1.73 mGFR calculated with GFR: 27 mL/min/1.73 m22
CrCl calculated with Cockroft-Gault: 33 mL/min/1.73 mCrCl calculated with Cockroft-Gault: 33 mL/min/1.73 m22
SCr Weight Height
2.85 mg/dL 86 kg 5‘10"
Which should I use?Which should I use?
Both!Both! Medication adjustments should be initially Medication adjustments should be initially
based on creatinine clearance (Cockroft-based on creatinine clearance (Cockroft-Gault)Gault)
Include the patient’s clinical picture when Include the patient’s clinical picture when determining optimal dosingdetermining optimal dosing
MDRD is more accurate as the severity of MDRD is more accurate as the severity of renal disease increases renal disease increases
Wargo et al. Comparison of the Modification of Diet in Renal Disease and Cockroft-Gault Equations for Antimicrobial Dosage Adjustments. The Annals of Pharmacotherapy. 2006;40:1248-1253
Beware!Beware!
Factors that falsely ELEVATE creatinineFactors that falsely ELEVATE creatinine DehydrationDehydration TMP-SMXTMP-SMX
Factors that falsely DECREASE creatinineFactors that falsely DECREASE creatinine Small muscle massSmall muscle mass Liver diseaseLiver disease
Dosing in Renal FailureDosing in Renal Failure
1.1. Calculate CrCl using Cockroft-gault Calculate CrCl using Cockroft-gault formulaformula
2.2. Use a reference to identify renal dosing Use a reference to identify renal dosing parametersparameters
3.3. Identify suggested dosage adjustmentIdentify suggested dosage adjustment
4.4. Determine if the dose reduction is Determine if the dose reduction is logical and appropriate for your patientlogical and appropriate for your patient
Factors to Consider when Factors to Consider when Adjusting DoseAdjusting Dose
CrCl is a STARTING POINT!CrCl is a STARTING POINT! Remember this is just an ESTIMATERemember this is just an ESTIMATE
Toxicities of antibioticToxicities of antibiotic Cephalosporin vs. aminoglycosideCephalosporin vs. aminoglycoside
Clinical conditionClinical condition SCr trends, sepsis, stability of patientSCr trends, sepsis, stability of patient
Infection being treatedInfection being treated Meningitis vs. pneumonia vs. bacteremiaMeningitis vs. pneumonia vs. bacteremia
Target organismTarget organism ESBL vs. intermediate resistance vs. susceptibleESBL vs. intermediate resistance vs. susceptible
Stages of Kidney DiseaseStages of Kidney DiseaseStageStage DescriptionDescription GFR (mL/min/1.73 mGFR (mL/min/1.73 m22))
11 Kidney damage with Kidney damage with normal GFRnormal GFR
≥≥9090
22 Kidney damage with Kidney damage with mild ↓ in GFRmild ↓ in GFR
60-8960-89
33 Moderate ↓ GFRModerate ↓ GFR 30-5930-59
44 Severe ↓ GFRSevere ↓ GFR 15-2915-29
55 Kidney FailureKidney Failure <15 (or dialysis)<15 (or dialysis)
Adapted from the National Kidney Foundation
DialysisDialysis
Use of a Use of a semi permeablesemi permeable membrane to membrane to remove solutes that are ineffectively remove solutes that are ineffectively cleared via the kidney during renal failurecleared via the kidney during renal failure Pore size of membrane determines the Pore size of membrane determines the
maximum size solute that can be removedmaximum size solute that can be removed i.e. large molecules (vancomycin)=not removedi.e. large molecules (vancomycin)=not removed
Volume of distribution determines extent of Volume of distribution determines extent of removalremoval i.e. large Vd (digoxin)=not removedi.e. large Vd (digoxin)=not removed
Rowland, Malcolm (1995). Clinical Pharmacokinetics: Concepts and Applications. 3rd Ed.USA: Lippincott, Williams, and Wilkins. 448-453.
DialysisDialysis
Manufacturer’s usually provide dosing Manufacturer’s usually provide dosing recommendationsrecommendations Decrease of total doseDecrease of total dose Increase in interval of dose (after dialysis)Increase in interval of dose (after dialysis) Decrease of dose plus a supplemental dose Decrease of dose plus a supplemental dose
after dialysisafter dialysis
Use pharmacokinetics (Vd, molecule Use pharmacokinetics (Vd, molecule size) to make an educated guesssize) to make an educated guess
Rowland, Malcolm (1995). Clinical Pharmacokinetics: Concepts and Applications. 3rd Ed.USA: Lippincott, Williams, and Wilkins. 448-453.
Continuous DialysisContinuous Dialysis CRRT: continuous renal replacement therapyCRRT: continuous renal replacement therapy Primary use in pts that are hemodynamically Primary use in pts that are hemodynamically
unstableunstable ICU settingICU setting Septic patients on ≥ 1 antimicrobialSeptic patients on ≥ 1 antimicrobial
Slow, continuous solute removalSlow, continuous solute removal Various types (filtration, ultrafiltration, etc.)Various types (filtration, ultrafiltration, etc.) Depending on type of CRRT, usually correlates Depending on type of CRRT, usually correlates
with a CrCl of 50 mL/min/1.73 mwith a CrCl of 50 mL/min/1.73 m22
Most references include specific information for Most references include specific information for dosing during CRRTdosing during CRRT
Trotman et al. Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy. CID. 2005;41:1159-1166
Adjusting Antimicrobials Adjusting Antimicrobials During DialysisDuring Dialysis
1.1. Determine pt’s underlying renal functionDetermine pt’s underlying renal function2.2. Determine kinetics of antimicrobial in Determine kinetics of antimicrobial in
dialysisdialysis1.1. Molecule size vs. filter pore sizeMolecule size vs. filter pore size2.2. Volume of distribution of antimicrobialVolume of distribution of antimicrobial
3.3. Decrease dose as Decrease dose as recommended/clinically appropriaterecommended/clinically appropriate
4.4. Check peaks/troughs as needed to Check peaks/troughs as needed to avoid accumulation or toxicityavoid accumulation or toxicity
ReferencesReferences
Package InsertPackage Insert Online ResourcesOnline Resources
Up-to-Date/Lexi-compUp-to-Date/Lexi-comp MicromedexMicromedex Facts & ComparisonsFacts & Comparisons
Sanford GuideSanford Guide ‘‘The Green Book’The Green Book’
Example #1: FluconazoleExample #1: Fluconazole A.Y. is a 46 y/o AAF who was recently admitted A.Y. is a 46 y/o AAF who was recently admitted
for cadaveric kidney transplant. The transplant for cadaveric kidney transplant. The transplant protocol calls for antifungal coverage protocol calls for antifungal coverage (fluconazole 200mg PO daily) for 6 months as (fluconazole 200mg PO daily) for 6 months as the patient tapers off immunosuppressive the patient tapers off immunosuppressive medications. medications.
Labs:Labs: Height: 5’6”Height: 5’6” Weight: 68 kgWeight: 68 kg SCr: 4.68 mg/dLSCr: 4.68 mg/dL UO: 40 cc/hrUO: 40 cc/hr
Example #1: FluconazoleExample #1: Fluconazole Weight:Weight:
IBW: 59.3 kgIBW: 59.3 kg % above IBW: 14%% above IBW: 14% Use ABW for calculationUse ABW for calculation
Calculated renal function:Calculated renal function: MDRD: 12 mL/min/1.73 mMDRD: 12 mL/min/1.73 m22
Cockroft-Gault: 16 ml/min/1.73 mCockroft-Gault: 16 ml/min/1.73 m22
Example #1: FluconazoleExample #1: Fluconazole
DiflucanDiflucan®® package insert states: package insert states:
Recommended Dose: 100mg PO dailyRecommended Dose: 100mg PO daily
Example #2: Pip/TazoExample #2: Pip/Tazo 72 y/o Hispanic female initially admitted for an 72 y/o Hispanic female initially admitted for an
acute decompensation of CHF, develops a acute decompensation of CHF, develops a Klebsiella pneumoniae Klebsiella pneumoniae UTI. Sensitivities come UTI. Sensitivities come back, resistant to everything except Zosyn. The back, resistant to everything except Zosyn. The team asks you for a recommendation . . . . team asks you for a recommendation . . . .
Labs:Labs:
1/191/19 1/201/20 1/221/22 1/231/23
ScrScr 0.9mg/dL0.9mg/dL 1.1mg/dL1.1mg/dL 1.24mg/dL1.24mg/dL 1.45mg/dL1.45mg/dL
WeightWeight HeightHeight UOUO
87 kg87 kg 5’4”5’4” 44 mL/hour44 mL/hour
Example #2: Pip/TazoExample #2: Pip/Tazo
WeightWeight IBW: 54.7 kgIBW: 54.7 kg % above Ideal: 59%% above Ideal: 59% Use ABW!!! (67.6 kg)Use ABW!!! (67.6 kg)
Calculated Renal FunctionCalculated Renal Function MDRD: 38 mL/min/1.73 mMDRD: 38 mL/min/1.73 m22
Cockroft-Gault: 37 mL/min/1.73 mCockroft-Gault: 37 mL/min/1.73 m22
Example #2: Pip/TazoExample #2: Pip/Tazo Package Insert:Package Insert:
Recommended Dose: Recommended Dose: 2.25gm IV every 6 hours2.25gm IV every 6 hours
Example #3: LevofloxacinExample #3: Levofloxacin
A 55 y/o Asian male is admitted for A 55 y/o Asian male is admitted for community-acquired pneumonia. It is community-acquired pneumonia. It is decided that his condition warrants IV decided that his condition warrants IV antibiotics. The physician wants you to antibiotics. The physician wants you to recommend an appropriate dose of recommend an appropriate dose of levofloxacinlevofloxacin
Labs:Labs: Height: 5’7”Height: 5’7” Weight: 67 kgWeight: 67 kg SCr: 1.75 mg/dLSCr: 1.75 mg/dL
Example #3: LevofloxacinExample #3: Levofloxacin
WeightWeight IBW: 66.1 kgIBW: 66.1 kg % above Ideal: 1%% above Ideal: 1% Use actual body weightUse actual body weight
Calculated Renal FunctionCalculated Renal Function MDRD: 43 mL/min/1.73 mMDRD: 43 mL/min/1.73 m22
Cockroft-Gault: 45 mL/min/1.73 mCockroft-Gault: 45 mL/min/1.73 m22
Example #3: LevofloxacinExample #3: Levofloxacin
Example #3: LevofloxacinExample #3: Levofloxacin
Recommended dose: 750mg every other dayRecommended dose: 750mg every other day
ConclusionsConclusions
Antimicrobial dose adjustments must be Antimicrobial dose adjustments must be made to avoid supratherapeutic serum made to avoid supratherapeutic serum levels and toxicity in renal failurelevels and toxicity in renal failure
Cockroft-Gault equation should be used to Cockroft-Gault equation should be used to determine antimicrobial dose adjustmentsdetermine antimicrobial dose adjustments
MDRD is useful in pts with severe renal MDRD is useful in pts with severe renal failurefailure
The clinical picture should be utilized to The clinical picture should be utilized to determine the correct antimicrobial dosedetermine the correct antimicrobial dose